Detalhe da pesquisa
1.
Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity.
Cell
; 163(3): 746-58, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26496612
2.
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
J Med Virol
; 95(1): e28157, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117402
3.
Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices.
J Am Chem Soc
; 143(36): 14748-14765, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490778
4.
Machine Learning Models Identify Inhibitors of SARS-CoV-2.
J Chem Inf Model
; 61(9): 4224-4235, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387990
5.
Structure activity relationship of novel antiviral nucleosides against Enterovirus A71.
Bioorg Med Chem Lett
; 30(23): 127599, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031923
6.
Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.
J Neurovirol
; 23(2): 186-204, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27761801
7.
A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
J Antimicrob Chemother
; 69(8): 2164-74, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777908
8.
In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
Arch Virol
; 159(6): 1279-91, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24311151
9.
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.
J Med Chem
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687966
10.
Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice.
Virol J
; 10: 221, 2013 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816343
11.
An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.
Vaccine
; 41(39): 5730-5741, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567799
12.
An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.
Vaccine
; 41(38): 5592-5602, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532610
13.
Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice.
Virology
; 580: 62-72, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780728
14.
An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Bunyavirales Order.
ACS Med Chem Lett
; 14(4): 506-513, 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077387
15.
Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5.
Antiviral Res
; 216: 105654, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327878
16.
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023.
Antiviral Res
; 217: 105678, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494979
17.
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2.
Nat Commun
; 14(1): 1733, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977673
18.
TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model.
iScience
; 25(10): 105074, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093377
19.
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice.
ACS Omega
; 7(36): 31935-31944, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097511
20.
Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2.
Res Sq
; 2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898342